PAMS
CTIC

Pictet Asset Management (Switzerland)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,130
Closed -$67.7K – 2059
2023
Q1 		$67.7K Buy
16,130
+4,596
+40% +$19.3K ﹤0.01% 1918
2022
Q4 		$69K Buy
+11,534
New +$69K ﹤0.01% 1928